Evidence map›Paper›PMID 15270731›Full record

ArticleImmunology2004

Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines.

Daniel Myrtek, Mathias Knoll, Timm Matthiesen, Sebastian Krause, Jens Lohrmann, Dirk Schillinger, Marco Idzko, J Christian Virchow, Karlheinz Friedrich, Werner Luttmann

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  8. Article
  9. Review
  10. Activation states of blood eosinophils in asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2014
    Review
  11. Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  12. Article
  13. Expression of IL-4/IL-13 receptors in differentiating human airway epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2010
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Daniel MyrtekDepartment of Pneumology, University Hospital Freiburg, Freiburg, Germany.
Mathias Knoll
Timm Matthiesen
Sebastian Krause
Jens Lohrmann
Dirk Schillinger
Marco Idzko
J Christian Virchow
Karlheinz Friedrich
Werner Luttmann
University Medical Center Freiburg · DEFriedrich Schiller University Jena · DEUniversity of Rostock · DECarl von Ossietzky Universität Oldenburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-13 (IL-13) is critical for the development of allergic asthma and is involved in the activation of eosinophils within the airways. IL-13 exerts its activity on target cells via the dimeric IL-13 receptor (IL-13R), which comprises the IL-13 receptor alpha1-chain (IL-13Ralpha1) as a specific component. The aim of this study was to investigate the expression of the IL-13Ralpha1-chain on primary human eosinophilic granulocytes. Furthermore, it addresses the regulatory influence of cytokines on the level of surface abundance of this receptor subunit. Expression of IL-13- and IL-4-receptor subunits in purified primary human eosinophils was monitored at the messenger RNA level by reverse transcription polymerase chain reaction and at the protein level by flow cytometry. For the analysis of IL-13Ralpha1 surface expression, a new monoclonal antibody, which was generated using genetic immunization, was employed. Different cytokines with established activity on eosinophils were studied with regard to their influence on IL-13Ralpha1 in vitro by flow cytometry. Whereas IL-13 and IL-4 had inhibitory effects on IL-13Ralpha1 expression on eosinophils, interferon-gamma, tumour necrosis factor-alpha, and, to the largest extent, transforming growth factor-beta, enhanced the expression of this receptor subunit. A positive regulatory response evoked by transforming growth factor-beta and interferon-gamma does not prevent inhibitory effects caused by IL-13. These findings suggest a regulatory cytokine network influencing the reactivity of eosinophils to IL-13.

Indexed as

Cells, CulturedCytokinesDown-RegulationEosinophilsHumansInterleukin-13Interleukin-13 Receptor alpha1 SubunitMonocytesReceptors, InterleukinReceptors, Interleukin-13Reverse Transcriptase Polymerase Chain ReactionRNA, MessengerTransforming Growth Factor betaUp-RegulationCytokinesIL13RA1 protein, humanInterleukin-13Interleukin-13 Receptor alpha1 SubunitReceptors, InterleukinReceptors, Interleukin-13RNA, MessengerTransforming Growth Factor beta

Identifiers

PMID15270731
PMCPMC1782525
OpenAlexW1984819741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.